RSS   Newsletter   Contact   Advertise with us
Post Online Media

OncoSec Medical promotes Sharron Gargosky to chief clinical officer

OncoSec MedicalOncoSec Medical, a company developing cancer immunotherapies, announced Sharron Gargosky has been appointed to chief clinical and regulatory officer

Dr. Gargosky previously served as OncoSec's Head of Clinical Development and Operations, as a consultant, since February 2016.

Article continues below

READ MORE OncoSec Medical appoints SVP, business development

Dr. Gargosky has over 20 years of experience in clinical development and operations in the field of pharmaceutical and biologic development having managed global programs from early research phase through the U.S. Food & Drug Administration (FDA) approval process.

Recently, Dr. Gargosky was the Chief Technical and Operations Officer at Prima Biomed where she led the immuno-oncology program in ovarian and pancreatic cancer overseeing international manufacturing, regulatory approvals, and clinical execution.

Prior to Prima Biomed, she served in positions of increasing clinical and scientific responsibility at biopharmaceutical companies including Pharmacia, Medicis, and Hyperion Therapeutics.

Dr. Gargosky received her PhD from the University of Adelaide, Australia and completed her postdoctoral fellowship at Stanford University.


 LATEST MOVES FROM California 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy